Microbiological and pharmacological evaluation of BL-C 43, a new semisynthetic derivative of coumermycin A1.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001419:Bacteria / Q000187:drug effects*; D003374:Coumarins / Q000494:pharmacology* / Q000627:therapeutic use; D007239:Infections / Q000188:drug therapy*; D051379:Mice; D008826:Microbial Sensitivity Tests; D011758:Pyrroles / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D003374:Coumarins; D011758:Pyrroles